Trial Profile
Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tadalafil/tamsulosin (Primary) ; Tadalafil; Tamsulosin
- Indications Benign prostatic hyperplasia
- Focus Registrational; Therapeutic Use
- Sponsors Chong Kun Dang
- 15 Aug 2017 New trial record